NewsMV
Kyndryl shares have declined to $11.55 over the past six months, marking a 10.5% loss that lags the S&P 500's 15.9% gain during the same period.
Analysts at StockStory argue that despite the lower price, the company's fundamentals do not meet their standards for investment quality.
The primary concern cited is a five-year trend of weak demand, with sales falling at an annual rate of 5%.
This sustained contraction is viewed as a sign of lacking business quality, a factor that differentiates top-performing companies from those experiencing only short-term success.
Keep reading